Leave a comment

35 SUBARACHNOID HEMORRHAGE

35 SUBARACHNOID HEMORRHAGE
Harrison’s Manual of Medicine

35

SUBARACHNOID HEMORRHAGE

Bibliography

Most common cause of nontraumatic subarachnoid hemorrhage (SAH) is rupture of an intracerebral aneurysm; other etiologies include mycotic aneurysms in subacute bacterial endocarditis, bleeding dyscrasias, and rarely infections or tumors. Approximately 3–4% of the population harbor aneurysms; rupture risk for aneurysms ³10mm in size is 0.5% per year.
CLINICAL PRESENTATION   Sudden, severe headache, often with transient loss of consciousness at onset; vomiting is common. Bleeding may injure adjacent brain tissue and produce focal neurologic deficits. A progressive third nerve palsy with severe headache suggests posterior communicating artery aneurysm. In addition to dramatic presentations, aneurysms can undergo small ruptures with leaks of blood into the subarachnoid space (sentinel bleeds).
LABORATORY EVALUATION   CT   Noncontrast CT is the initial study of choice and usually demonstrates the hemorrhage. On occasion, LP is required for diagnosis of suspected SAH if CT is nondiagnostic.
Cerebral Angiography   Necessary to define the anatomy, location, and type of vascular malformation, such as aneurysm or arteriovenous malformation; also assesses vasospasm. Usually performed as soon as possible after diagnosis of SAH is made.
ECG   ST-segment changes, prolonged QRS complex, increased QT interval, and prominent or inverted T waves often present; some changes reflect SAH, others indicate associated myocardial ischemic injury.
Blood Studies   Closely follow serum electrolytes and osmolality; hyponatremia frequently develops several days after SAH. Cerebral salt wasting is common, and supplemental sodium is used to overcome renal losses.

TREATMENT
Standard management includes bed rest in a quiet darkened room, analgesics, and stool softeners. Anticonvulsants are begun at diagnosis and continued at least until the aneurysm is treated. Risk of early rebleeding is high (20–30% over 2 weeks), thus early treatment (within 1–3 days) is advocated to avoid rerupture and allow aggressive treatment of vasospasm. Neurosurgical clipping of the aneurysm neck is the most common treatment, although newer endovascular techniques are also possible. Severe hydrocephalus may require urgent placement of a ventricular catheter for external CSF drainage. Blood pressure is carefully monitored and regulated to assure adequate cerebral perfusion while avoiding excessive elevations. Symptomatic vasospasm may occur by day 4 and continue through day 14, leading to focal ischemia and possible stroke. Medical treatment, including nimodipine, may minimize the neurologic sequelae of vasospasm. Cerebral perfusion can be improved in vasospasm by increasing mean arterial pressure with vasopressor agents such as neosynephrine or dopamine. Intravascular volume can be expanded with crystalloid. Angioplasty of the cerebral vessels can be effective in cases of severe vasospasm when ischemic symptoms appear despite maximal medical therapy.

Bibliography

For a more detailed discussion, see Smith WS, Hauser SL, Easton JD: Cerebrovascular Diseases, Chap. 361, p. 2369 in HPIM-15.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: